Transbronchial photodynamic therapy for peripheral lung cancer – A pilot study

Key Points

• Transbronchial photodynamic therapy achieved modest tumor control for peripheral lung cancer, indicating its potential.
• The light dose of 200 J/cm was used, demonstrating a favorable acute safety profile in a small cohort.
• Pilot observational study confirmed the technique's feasibility for delivering light to difficult peripheral lesions.
• Future Phase I trials may enable optimized dosing strategies, enhancing treatment effectiveness and safety.

Abstract